Security key
98400H102
XBiotech Inc. - Common Shares, no par value (XBIT)
CUSIP: 98400H102
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 37
- Total 13F value
- $81
- Share change
- 0
- SEC-reported price per share
- $2.19
- Number of holders
- 1
- Shares outstanding
- 32,315,113
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
1
XBIT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
XBiotech Inc. SEC filings
XBiotech Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98400H102
Recent filing periods:
Ownership snapshot
Top reported holders of XBIT - XBiotech Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
John Simard
Disclosed value leader
John Simard
Comparable rows
2/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 18%
13 rows are not safely comparable across share classes.
13D/G row: John Simard
Showing 1-6 of 15 holder rows.
Quick read
John Simard leads the comparable SEC ownership view at 18%.
2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens John Simard's linked filing trail.
Comparable ownership
Top 2
John Simard
18%
W. Thorpe McKenzie
9.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| John Simard |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
18%
Reported 13D/G
· 31 Dec 2025
|
$13,784,658
5,719,775 shares
|
-$2,180,460 | 31 Dec 2025 |
| W. Thorpe McKenzie |
13D/G
3/4/5
Director, 10%+ Owner
|
9.8%
Reported 13D/G
· 31 Dec 2025
|
$7,245,084
3,006,259 shares
|
+$45,188 | 31 Dec 2025 |
| Thomas Martin Kuendig |
3/4/5
Director
|
—
mixed-class rows
|
$1,017,000
379,115 shares
mixed-class rows
|
— | 01 Oct 2025 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$738,636
321,146 shares
|
— | 30 Jun 2026 |
| Craig Evan Rademaker |
3/4/5
Director
|
—
mixed-class rows
|
$579,638
263,089 shares
mixed-class rows
|
— | 01 Oct 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$492,755
214,116 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
37
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q3 2025 Across Filers
Q3 2025 holders
45
Q3 2026 holders
1
Holder diff
-44
| Investor | Q3 2025 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend